A trans-institutional team of researchers at Vanderbilt University Medical Center and Vanderbilt University has received an $11 million Cancer Moonshot grant to build a single-cell resolution atlas to map out the routes that benign colonic polyps take to progress to colorectal cancer, the third most common cancer among both men and women in the United States.

A potential cancer drug aimed at enhancing the effectiveness of ionizing radiation in lung cancer patients is a step closer to development with funding support from the Small Business Innovation Research (SBIR) program.

The T.J. Martell Foundation’s 6th Annual Chic Awearness fundraising event that supports ovarian cancer research at Vanderbilt-Ingram Cancer Center will be held Monday, Sept. 24, 6:30 – 8:30 p.m.

The Centers for Disease Control and Prevention released new clinical recommendations for health care providers treating children with mild traumatic brain injury, often referred to as concussion.

Vanderbilt-Ingram Cancer Center researchers have answered questions about the incidence and timing of rare but sometimes fatal reactions to the most widely prescribed class of immunotherapies.

Vanderbilt’s Kenneth Gaines, MD, MBA, professor of Clinical Neurology, has received a $15.7 funding award to determine if stroke outcomes can be improved with a redesigned and better-integrated model of care.